Study to generate evidence on impact of pharmaceutical industry-led medicines...
Study of Novartis Access program in Kenya demonstrates it is possible to evaluate major pharmaceutical companies' access programs using robust, 'gold standard' methods.
View ArticleTwo-drug combinations containing calcium channel blocker significantly lowers BP
In the largest randomized controlled trial of treatment for high blood pressure ever conducted in sub-Saharan Africa, two frontline two-drug combinations that included the long-acting calcium channel...
View ArticleAntihypertensive drug associated with lower risk of gout
Affecting more than 7 million adults in the United States, gout is characterized by a sudden onset of pain, swelling and stiffness in the joints and caused by the formation of urate crystal in small...
View ArticleStrong evidence several FDA approved drugs block SARS-CoV-2 in relevant...
Now, a new study describes how compounds that restore the normal transcriptional conditions following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can be used to reduce...
View ArticleCommon high blood pressure medications do not increase risk of depression
None of the 41 most common high blood pressure medications increased the risk of depression, while nine medications appeared to lower it, according to a study from Denmark, published today in...
View ArticleScientists identify new therapeutic targets for SARS-CoV-2
To identify new potential therapeutic targets for SARS-CoV-2, a team of scientists at the New York Genome Center, New York University, and the Icahn School of Medicine at Mount Sinai, performed a...
View ArticleIntensive blood-pressure control benefits older hypertensive patients
Aggressive blood pressure treatment in older hypertensive patients lowers the incidence of cardiovascular events compared to standard therapy, without increasing adverse outcomes. That's the finding of...
View ArticleExploring the potential utility of calcium channel inhibitors in SARS-CoV-2...
In a new study, researchers discuss the role of calcium signaling pathways as targets of inhibition in potential new antiviral therapeutic pathways for SARS-CoV-2.
View ArticleIdentifying and managing drug-drug interactions key to the safe use of...
Researchers compiled evidence-based recommendations in consultation with European and North American clinicians and pharmacologists for recognizing and managing drug-drug interactions with...
View ArticleNew insights into the link between EMFs, calcium and Alzheimer’s disease
For almost a quarter of a century, researchers have been studying and publishing on the effect of calcium on Alzheimer's Disease. Research has led to the development of the calcium hypothesis of...
View Article
